References
- List A. F., Gonzalez-Osete G., Kummet T., Doll D. C. “Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration”. Am. J. Med 1991; 90(2)274–276
- Byrd J. C., Edenfield W. J., Shields D. J., Dawson N. A. “Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review”. J. Clin. Oncol 1995; 13(7)1800–1816
- Roth M. J., Medeiros L. J., Elenitoba-Johnson K., Kuchnio M., Jaffe E. S., Stetler-Stevenson M. “Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections”. Arch. Pathol. Lab. Med 1995; 119(9)790–798
- Yamauchi K., Yasuda M. “Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature”. Cancer 2002; 94(6)1739–1746
- Neiman R. S., Barcos M., Berard C., Bonner H., Mann R., Rydell R. E., Bennett J. M. “Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases”. Cancer 1981; 48(6)1426–1437
- Hagihara M., Kobayashi H., Miyachi H., Ogawa T. “Clinical heterogeneity in acute myelogenous leukemia with the 8:21 translocation”. Keio J. Med 1991; 40(2)90–93
- Lillington D. M., Jaju R. J., Shankar A. G., Neat M., Kearney L., Young B. D., Saha V. “Cytogenetic and molecular evidence of marrow involvement in extramedullary acute myeloid leukaemia”. Br. J. Haematol 2000; 110(3)547–551
- Krishnan K., Ross C. W., Adams P. T., Pereira A., Roth M. S. “Neural cell-adhesion molecule (CD 56)-positive, t(8;21) acute myeloid leukemia (AML, M-2) and granulocytic sarcoma”. Ann. Hematol 1994; 69(6)321–323
- Byrd J., Weiss R., Arthur D., Lawrence D., Baer M., Davey F., Trikha E., Carroll A., Tantravahi R., Qumsiyeh M., Patil S., Moore J., Mayer R., Schiffer C., Bloomfield C. “Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461”. J. Clin. Oncol 1997; 15(2)466–475
- Martinelli G., Vianelli N., De Vivo A., Ricci P., Remiddi C., Testoni N., Visani G., Baravelli S., Farabegoli P., Tura S. Leuk. Lymphoma 1997; 24(3–4)349–353
- Imrie K. R., Kovacs M. J., Selby D., Lipton J., Patterson B. J., Pantalony D., Poldre P., Ngan B. Y., Keating A. “Isolated chloroma: the effect of early antileukemic therapy”. Ann. Intern. Med 1995; 123(5)351–353